439 related articles for article (PubMed ID: 29032131)
1. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
[TBL] [Abstract][Full Text] [Related]
2. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
McAlister FA; Zheng Y; Westerhout CM; Buse JB; Standl E; McGuire DK; Van de Werf F; Green JB; Armstrong PW; Holman RR;
Eur J Heart Fail; 2020 Nov; 22(11):2026-2034. PubMed ID: 32621557
[TBL] [Abstract][Full Text] [Related]
3. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
[TBL] [Abstract][Full Text] [Related]
4. Glycemic control and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: insight from ventricular remodeling using cardiac MRI.
Shi K; Zhang G; Fu H; Li XM; Gao Y; Shi R; Xu HY; Li Y; Guo YK; Yang ZG
Cardiovasc Diabetol; 2024 Apr; 23(1):148. PubMed ID: 38685007
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus.
Fröhlich H; Bossmeyer A; Kazmi S; Goode KM; Agewall S; Atar D; Grundtvig M; Frey N; Cleland JGF; Frankenstein L; Clark AL; Täger T
Clin Res Cardiol; 2024 Jun; 113(6):822-830. PubMed ID: 37608126
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry.
Targher G; Dauriz M; Tavazzi L; Temporelli PL; Lucci D; Urso R; Lecchi G; Bellanti G; Merlo M; Rossi A; Maggioni AP;
Int J Cardiol; 2016 Jan; 203():587-93. PubMed ID: 26574932
[TBL] [Abstract][Full Text] [Related]
8. Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acute Heart Failure.
Núñez J; Bonanad C; Navarro JP; Bondanza L; Artero A; Ventura S; Núñez E; Miñana G; Sanchis J; Real J
Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):852-60. PubMed ID: 25792287
[TBL] [Abstract][Full Text] [Related]
9. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus.
Jang SY; Jang J; Yang DH; Cho HJ; Lim S; Jeon ES; Lee SE; Kim JJ; Kang SM; Baek SH; Cho MC; Choi DJ; Yoo BS; Kim KH; Park SK; Lee HY
Cardiovasc Diabetol; 2021 Sep; 20(1):180. PubMed ID: 34496864
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study.
Kong MG; Jang SY; Jang J; Cho HJ; Lee S; Lee SE; Kim KH; Yoo BS; Kang SM; Baek SH; Choi DJ; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Lim S; Park SK; Lee HY
Cardiovasc Diabetol; 2020 May; 19(1):49. PubMed ID: 32359358
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction.
Lin SN; Phang KK; Toh SH; Chee KH; Zaman Huri H
Front Endocrinol (Lausanne); 2020; 11():448. PubMed ID: 32754118
[No Abstract] [Full Text] [Related]
12. Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.
Lawson CA; Zaccardi F; McCann GP; Davies MJ; Kadam UT; Khunti K
JAMA Netw Open; 2019 Dec; 2(12):e1916447. PubMed ID: 31790564
[TBL] [Abstract][Full Text] [Related]
13. Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Cosmi F; Shen L; Magnoli M; Abraham WT; Anand IS; Cleland JG; Cohn JN; Cosmi D; De Berardis G; Dickstein K; Franzosi MG; Gullestad L; Jhund PS; Kjekshus J; Køber L; Lepore V; Lucisano G; Maggioni AP; Masson S; McMurray JJV; Nicolucci A; Petrarolo V; Robusto F; Staszewsky L; Tavazzi L; Teli R; Tognoni G; Wikstrand J; Latini R
Eur J Heart Fail; 2018 May; 20(5):888-895. PubMed ID: 29488676
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ
Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591
[TBL] [Abstract][Full Text] [Related]
15. Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Lawson CA; Mamas MA; Jones PW; Teece L; McCann G; Khunti K; Kadam UT
JAMA Netw Open; 2018 Dec; 1(8):e185489. PubMed ID: 30646293
[TBL] [Abstract][Full Text] [Related]
16. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR).
Arnold SV; Echouffo-Tcheugui JB; Lam CSP; Inzucchi SE; Tang F; McGuire DK; Goyal A; Maddox TM; Sperling LS; Fonarow GC; Masoudi FA; Kosiborod M
Am Heart J; 2018 Sep; 203():25-29. PubMed ID: 30015065
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study.
Weir DL; McAlister FA; Senthilselvan A; Minhas-Sandhu JK; Eurich DT
JACC Heart Fail; 2014 Dec; 2(6):573-82. PubMed ID: 24998080
[TBL] [Abstract][Full Text] [Related]
18. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.
Elder DH; Singh JS; Levin D; Donnelly LA; Choy AM; George J; Struthers AD; Doney AS; Lang CC
Eur J Heart Fail; 2016 Jan; 18(1):94-102. PubMed ID: 26663216
[TBL] [Abstract][Full Text] [Related]
19. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
20. Contemporary risk estimates of three HbA
Skrtic S; Cabrera C; Olsson M; Schnecke V; Lind M
Heart; 2017 Mar; 103(5):353-358. PubMed ID: 27647169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
